1. Sung, H, Ferlay, J, Siegel, RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249.
Google Scholar | Crossref | Medline2. Zhang, S, Sun, K, Zheng, R, et al. Cancer incidence and mortality in China, 2015. J Natl Cancer Center. 2021;1:2-11.
Google Scholar | Crossref3. Toledano, A, Rao, S, Frenkel, M, et al. Integrative oncology: an international perspective from six countries. Integr Cancer Ther. 2021;20:15347354211004730.
Google Scholar | SAGE Journals4. Sanford, NN, Sher, DJ, Ahn, C, Aizer, AA, Mahal, BA. Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States. JAMA Oncol. 2019;5:735-737.
Google Scholar | Crossref | Medline5. Yang, G, Lee, R, Zhang, H, Gu, W, Yang, P, Ling, C. National survey of China’s oncologists’ knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine. Oncotarget. 2017;8:13440-13449.
Google Scholar | Crossref | Medline6. Ernst, E. Exploring the science of complementary and alternative medicine: third strategic plan, 2011-2015. Focus Altern Compl Ther. 2012;17:e7-e7.
Google Scholar | Crossref7. Witt, CM, Balneaves, LG, Cardoso, MJ, et al. A comprehensive definition for integrative oncology. J Natl Cancer Inst Monographs. 2017;2017(52):lgx012.
Google Scholar8. Ling, CQ, Wang, LN, Wang, Y, et al. The roles of traditional Chinese medicine in gene therapy. J Integr Med. 2014;12:67-75.
Google Scholar | Crossref | Medline9. Ji, Q, Luo, YQ, Wang, WH, Liu, X, Li, Q, Su, SB. Research advances in traditional Chinese medicine syndromes in cancer patients. J Integr Med. 2016;14:12-21.
Google Scholar | Crossref | Medline10. McQuade, JL, Meng, Z, Chen, Z, et al. Utilization of and attitudes towards traditional Chinese medicine therapies in a Chinese cancer hospital: a survey of patients and physicians. Evid Based Complement Alternat Med. 2012;2012:504507.
Google Scholar | Crossref | Medline11. Yang, G, Zhang, H, Gan, Z, Fan, Y, Gu, W, Ling, C. Discrepant views of oncologists and cancer patients on complementary and alternative medicine in a Chinese General Hospital. Integr Cancer Ther. 2018;17:451-457.
Google Scholar | SAGE Journals | ISI12. Zhang, H, Yang, G, Zhang, W, Gu, W, Su, Y, Ling, C. Characteristic analysis of complementary and alternative medicine in randomized controlled trials of oncology: a comparison of published studies. Integr Cancer Ther. 2018;17:551-557.
Google Scholar | SAGE Journals | ISI13. Yang, G, Zhang, W, Zhang, H. Response to “characteristic analysis of complementary and alternative medicine in randomized controlled trials of oncology: a comparison of published studies”. Integr Cancer Ther. 2019;18:1534735419851867.
Google Scholar | SAGE Journals | ISI14. Yang, G, Zhang, H, Yang, Y. Challenges and countermeasures of integrative cancer therapy in the epidemic of COVID-19. Integr Cancer Ther. 2020;19:1534735420912811.
Google Scholar | SAGE Journals | ISI15. Bashshur, RL, Doarn, CR, Frenk, JM, Kvedar, JC, Shannon, GW, Woolliscroft, JO. Beyond the COVID pandemic, telemedicine, and health care. Telemed J E Health. 2020;26:1310-1313.
Google Scholar | Crossref | Medline